Literature DB >> 11928079

Idiopathic portal hypertension and its pathology.

Masahiko Okudaira1, Makoto Ohbu, Kunio Okuda.   

Abstract

Idiopathic portal hypertension (IPH) is a disorder of unknown etiology, clinically characterized by portal hypertension (varices and portosystemic collateral vessels), splenomegaly, and anemia (hypersplenism). A similar disorder is called noncirrhotic portal fibrosis in India, and hepatoportal sclerosis seems to be the counterpart in the United States. This disease is uncommon in developed countries. Middle-aged women are more prone to IPH in Japan. The liver has no cirrhosis or pseudonodule formation, and the principal pathologic changes are considerable portal fibrosis, devastation of intrahepatic terminal portal radicles, and parenchymal atrophy of the liver secondary to portal malperfusion. The characteristic portal hemodynamics include intrahepatic presinusoidal portal hypertension, increased splenic and portal vein blood flow, and increased intrahepatic portal resistance. The prognosis is generally good depending on the management of bleeding varices. Although the etiology is obscure, certain immunologic abnormalities seem to play an etiologic role in Japanese patients, and the incidence has markedly declined in recent years in Japan, indirectly suggesting a role of infection. The theory that IPH represents an undiagnosed intrahepatic portal vein thrombosis is refuted.

Entities:  

Mesh:

Year:  2002        PMID: 11928079     DOI: 10.1055/s-2002-23207

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  31 in total

1.  Implications of portal vein thrombosis after splenectomy for patients with idiopathic portal hypertension.

Authors:  Teijiro Hirashita; Masayuki Ohta; Seiichiro Kai; Takashi Masuda; Hidetoshi Eguchi; Yukio Iwashita; Tadashi Ogawa; Seigo Kitano
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

2.  Endoscopic injection sclerotherapy with ethanolamine oleate with iopamidol for esophagojejunal varices in idiopathic portal hypertension.

Authors:  Koichi Soga; Koichi Tomikashi; Ki-ichiro Miyawaki; Kotaro Okuda; Yusuke Sugiyama; Shuji Sekikawa; Naoki Wakabayashi; Hideyuki Konishi; Shoji Mitsufuji; Keisho Kataoka; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2008-09-20       Impact factor: 3.199

3.  The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.

Authors:  Thomas D Schiano; Alison Uriel; Douglas T Dieterich; M Isabel Fiel
Journal:  Virchows Arch       Date:  2010-11-06       Impact factor: 4.064

4.  Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients.

Authors:  Sanjiv Saigal; Nabeen C Nayak; Deepali Jain; Vinay Kumaran; Ravi Mohanka; Neeraj Saraf; Amit Rastogi; Naimesh Mehta; Samiran Nundy; Arvinder Soin
Journal:  Hepatol Int       Date:  2011-01-12       Impact factor: 6.047

Review 5.  Noncirrhotic portal hypertension.

Authors:  Harshal Rajekar; Rakesh K Vasishta; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 6.  Pathology of idiopathic non-cirrhotic portal hypertension.

Authors:  Maria Guido; Samantha Sarcognato; Diana Sacchi; Guido Colloredo
Journal:  Virchows Arch       Date:  2018-04-12       Impact factor: 4.064

7.  Peliosis hepatis as an early histological finding in idiopathic portal hypertension: A case report.

Authors:  Annalisa Berzigotti; Donatella Magalotti; Paola Zappoli; Cristina Rossi; Francesco Callea; Marco Zoli
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

Review 8.  Idiopathic portal hypertension and extrahepatic portal venous obstruction.

Authors:  Rajeev Khanna; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-02-20       Impact factor: 6.047

9.  Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension.

Authors:  Azusa Kitao; Yasunori Sato; Seiko Sawada-Kitamura; Kenichi Harada; Motoko Sasaki; Hiroyasu Morikawa; Susumu Shiomi; Masao Honda; Osamu Matsui; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

10.  Life-threatening hypersplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature.

Authors:  Jan Däbritz; Jennifer Worch; Ulrike Materna; Bernward Koch; Gabriele Koehler; Christina Duck; Michael C Frühwald; Dirk Foell
Journal:  BMC Gastroenterol       Date:  2010-10-20       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.